<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37083797</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>16</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>21</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Combined Tui na and Western medicine treatment improves pulmonary function and quality of life in patients with amyotrophic lateral sclerosis: A case report.</ArticleTitle><Pagination><StartPage>e33612</StartPage><MedlinePgn>e33612</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e33612</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000033612</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Amyotrophic lateral sclerosis is a rare disease that cannot be cured. We report a case of a patient with amyotrophic lateral sclerosis whose pulmonary function and quality of life were improved by a combined tui na treatment and Western medicine.</AbstractText><AbstractText Label="PATIENT CONCERNS" NlmCategory="METHODS">A 48-year-old male was diagnosed with ALS 1 year ago and was treated with western medicine and herbal medicine with no significant effect. This time, he was admitted to our department because of slurred speech, coughing and choking, and weakness of the left upper limb for more than 1 year.</AbstractText><AbstractText Label="INTERVENTION AND OUTCOME" NlmCategory="RESULTS">After 1 month of treatment with tui na and traditional western medicine, the patient's lung function and quality of life improved and he was discharged from the hospital.</AbstractText><AbstractText Label="DIAGNOSES" NlmCategory="METHODS">Motor neuron disease. Amyotrophic lateral sclerosis.</AbstractText><AbstractText Label="LESSONS" NlmCategory="CONCLUSIONS">The physiological function of ALS patients can be improved through the intervention of tui na.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bei</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4447-4369</Identifier><AffiliationInfo><Affiliation>Zhijiang People's Hospital, Yichang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Haijing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Yunnan University of Chinese Medicine, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Cuiling</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Zhijiang People's Hospital, Yichang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Meidi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Zhijiang Hospital of Chinese Medicine, Yichang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Academy of Traditional Chinese Medicine, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei University of Chinese Medicine, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>14</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37083797</ArticleId><ArticleId IdType="pmc">PMC10118367</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000033612</ArticleId><ArticleId IdType="pii">00005792-202304210-00036</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xu L, Liu T, Liu L, et al. . Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol. 2020;267:944&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">31797084</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Boumediene F, Logroscino G, et al. . Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32:771&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedermeyer S, Murn M, Choi PJ. Respiratory failure in amyotrophic lateral sclerosis. Chest. 2019;155:401&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29990478</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomblez L, Bensimon G, Leigh PN, et al. . Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis/riluzole study group ii. Lancet. 1996;347:1425&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">8676624</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulisz D. Amyotrophic lateral sclerosis: disease state overview. Am J Manag Care. 2018;24:S320&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207670</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster LA, Salajegheh MK. Motor neuron disease: pathophysiology, diagnosis, and management. Am J Med. 2019;132:32&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30075105</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, Hardiman O, Al-Chalabi A, et al. . Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:480&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9513753</ArticleId><ArticleId IdType="pubmed">35334233</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman EL, Goutman SA, Petri S, et al. . Amyotrophic lateral sclerosis. Lancet. 2022;400:1363&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10089700</ArticleId><ArticleId IdType="pubmed">36116464</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, et al. . Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W, Chen X, Bao J, et al. . The use of integrative therapies in patients with amyotrophic lateral sclerosis in shanghai, China. Evid Based Complement Alternat Med. 2013;2013:613596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3865630</ArticleId><ArticleId IdType="pubmed">24363770</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardeny O, Bromberg M. The use of herbal supplements and alternative therapies by patients with amyotrophic lateral sclerosis (ALS). J Herb Pharmacother. 2006;5:23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">16520295</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisle S, Tennison M. Amyotrophic lateral sclerosis: the role of exercise. Curr Sports Med Rep. 2015;14:45&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25574882</ArticleId></ArticleIdList></Reference><Reference><Citation>Blatzheim K. Interdisciplinary palliative care, including massage, in treatment of amyotrophic lateral sclerosis. J Bodyw Mov Ther. 2009;13:328&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">19761955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Mun S, Park J, et al. . Complementary and alternative medicine use in amyotrophic lateral sclerosis cases in South Korea. Evid Based Complement Alternat Med. 2019;2019:4217057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6683772</ArticleId><ArticleId IdType="pubmed">31428170</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams J, Lee M, Peng W. Critical review of complementary and alternative medicine use in amyotrophic lateral sclerosis: prevalence and users&#x2019; profile, decision-making, information seeking, and disclosure in the face of a lack of efficacy. Neurodegener Dis. 2018;18:225&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">30248676</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang EJ, Jiang JH, Lee SM, et al. . Electroacupuncture reduces neuroinflammatory responses in symptomatic amyotrophic lateral sclerosis model. J Neuroimmunol. 2010;223:84&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">20460191</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang JH, Yang EJ, Baek MG, et al. . Anti-inflammatory effects of electroacupuncture in the respiratory system of a symptomatic amyotrophic lateral sclerosis animal model. Neurodegener Dis. 2011;8:504&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">21849797</ArticleId></ArticleIdList></Reference><Reference><Citation>Portaro S, Cimino V, Accorinti M, et al. . A promising tool for flail arm in amyotrophic lateral sclerosis rehabilitation: a case report. Eur J Phys Rehabil Med. 2019;55:515&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29904049</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemente S. Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: a case report. CNS Neurol Disord Drug Targets. 2012;11:933&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22998138</ArticleId></ArticleIdList></Reference><Reference><Citation>Bia&#x142;kowska J. Complex treatment of amyotrophic lateral sclerosis patient. Acta Clin Croat. 2019;58:757&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314291</ArticleId><ArticleId IdType="pubmed">32595261</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Sane H, Paranjape A, et al. . Multiple doses of cell therapy and neurorehabilitation in amyotrophic lateral sclerosis: a case report. Clin Pract. 2020;10:1242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533601</ArticleId><ArticleId IdType="pubmed">33072247</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan AA, Elkins J, Hassan HY. Case report: stem cell therapy in amyotrophic lateral sclerosis. F1000Res. 2021;10:1080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8762680</ArticleId><ArticleId IdType="pubmed">35087666</ArticleId></ArticleIdList></Reference><Reference><Citation>Urata R, Igawa T, Suzuki A, et al. . The short and intensive rehabilitation (SHAiR) program improves dropped head syndrome caused by amyotrophic lateral sclerosis: a case report. Medicina. 2022;58:452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8948869</ArticleId><ArticleId IdType="pubmed">35334628</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G, Wen Q, Cui B, et al. . Washed microbiota transplantation stopped the deterioration of amyotrophic lateral sclerosis: the first case report and narrative review. J Biomed Res. 2022;37:69&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9898040</ArticleId><ArticleId IdType="pubmed">35821195</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>